Financials GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:10 10/12/2024 GMT			5-day change	1st Jan Change
1,373.50 ^GBX	-0.69%		+2.39%	-5.29%

06:20pm	Global markets live: Nvidia, Oracle, MongoDB, Nvidia, GSK...
04:40pm	GSK: two strategic collaborations with Relation	CF

Projected Income Statement: GSK plc

income-statement-evolution-chart GSK-PLC

Fiscal Period: Dezember	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	33,754	34,099	34,114	29,324	30,328	31,157	32,307	34,216
Change	-	1.02%	0.04%	-14.04%	3.42%	2.73%	3.69%	5.91%
EBITDA ¹	11,968	9,530	11,330	10,449	11,635	10,218	11,101	12,272
Change	-	-20.37%	18.89%	-7.78%	11.35%	-12.18%	8.65%	10.55%
EBIT ¹	8,972	8,906	8,806	8,151	8,786	9,000	9,536	10,722
Change	-	-0.74%	-1.12%	-7.44%	7.79%	2.44%	5.95%	12.44%
Interest Paid ¹	-814	-848	-756	-803	-677	-581.3	-559.9	-496
Earnings before Tax (EBT) ¹	6,221	6,968	5,442	5,628	6,064	4,824	7,895	9,196
Change	-	12.01%	-21.9%	3.42%	7.75%	-20.45%	63.66%	16.49%
Net income ¹	4,645	5,749	4,385	14,956	4,928	3,672	5,782	6,587
Change	-	23.77%	-23.73%	241.07%	-67.05%	-25.48%	57.45%	13.92%
Announcement Date	05/02/20	03/02/21	09/02/22	01/02/23	31/01/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	8,899	9,090	7,624	8,646	8,739	7,418	8,092	9,077	9,527	9,780	6,929	7,829	7,376	6,951	7,178	8,147	8,052	7,363	7,884	8,012	7,634	-	-	-	-
Change	-	2.15%	-16.13%	13.41%	1.08%	-15.12%	9.09%	12.17%	4.96%	2.66%	-29.15%	12.99%	-5.79%	-5.76%	3.27%	13.5%	-1.17%	-8.56%	7.08%	1.62%	-4.72%	-100%	-	-	-
EBITDA ¹	2,376	2,869	2,526	2,024	2,111	2,041	2,822	3,860	2,406	3,317	2,639	3,561	1,602	2,732	2,622	3,351	2,930	2,992	3,152	3,712	1,726	-	-	-	-
Change	-	20.75%	-11.96%	-19.87%	4.3%	-3.32%	38.27%	36.78%	-37.67%	37.86%	-20.44%	34.94%	-55.01%	70.54%	-4.03%	27.8%	-12.56%	2.12%	5.35%	17.77%	-53.5%	-100%	-	-	-
EBIT ¹	1,852	2,675	1,749	2,665	1,817	1,881	2,158	2,874	1,893	2,613	2,008	2,605	1,595	2,092	2,170	2,772	1,752	2,443	2,513	2,761	1,346	-	-	-	-
Change	-	44.44%	-34.62%	52.37%	-31.82%	3.52%	14.73%	33.18%	-34.13%	38.03%	-23.15%	29.73%	-38.77%	31.16%	3.73%	27.74%	-36.8%	39.44%	2.87%	9.87%	-51.25%	-100%	-	-	-
Charge d'intérêts ¹	-195	-188	-227	-198	-234	-191	-185	-193	-187	-202	-183	-177	-244	-174	-152	-158	-193	-134	-150	-124	-158	-115	-130	-130	-160
Earnings before Tax (EBT) ¹	1,711	1,835	2,641	1,671	821	1,518	1,470	1,748	706	2,598	896	1,012	1,626	1,907	1,987	1,791	379	1,355	1,495	64	948	-	-	-	-
Change	-	7.25%	43.92%	-36.73%	-50.87%	84.9%	-3.16%	18.91%	-59.61%	267.99%	-65.51%	12.95%	60.67%	17.28%	4.2%	-9.86%	-78.84%	257.52%	10.33%	-95.72%	1,381.25%	-100%	-	-	-
Net income ¹	1,299	1,565	2,263	1,244	677	1,073	1,395	1,168	749	1,802	975	10,315	1,495	1,490	1,624	1,464	350	1,046	1,173	-58	800.5	-	-	-	-
Change	-	20.48%	44.6%	-45.03%	-45.58%	58.49%	30.01%	-16.27%	-35.87%	140.59%	-45.89%	957.95%	-85.51%	-0.33%	8.99%	-9.85%	-76.09%	198.86%	12.14%	-	-	-100%	-	-	-
Announcement Date	05/02/20	29/04/20	29/07/20	28/10/20	03/02/21	28/04/21	28/07/21	27/10/21	09/02/22	27/04/22	27/07/22	02/11/22	01/02/23	26/04/23	26/07/23	01/11/23	31/01/24	01/05/24	31/07/24	30/10/24	-	-	-	-	-

¹GBP in Million

Estimates

Forecast Balance Sheet: GSK plc

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	25,722	20,780	19,838	17,197	15,040	13,824	11,688	8,486
Change	-	-19.21%	-4.53%	-13.31%	-12.54%	-8.09%	-15.45%	-27.4%
Announcement Date	05/02/20	03/02/21	09/02/22	01/02/23	31/01/24	-	-	-

¹GBP in Million

Estimates

Cash Flow Forecast: GSK plc

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	1,265	1,226	1,172	1,143	1,314	1,378	1,467	1,545
Change	-	-3.08%	-4.4%	-2.47%	14.96%	4.85%	6.49%	5.29%
Free Cash Flow (FCF) ¹	5,073	5,406	4,437	6,260	5,454	3,517	5,529	6,521
Change	-	6.56%	-17.92%	41.09%	-12.88%	-35.52%	57.21%	17.95%
Announcement Date	05/02/20	03/02/21	09/02/22	01/02/23	31/01/24	-	-	-

¹GBP in Million

Estimates

Forecast Financial Ratios: GSK plc

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	35.46%	27.95%	33.21%	35.63%	38.36%	32.79%	34.36%	35.87%
EBIT Margin (%)	26.58%	26.12%	25.81%	27.8%	28.97%	28.89%	29.52%	31.34%
EBT Margin (%)	18.43%	20.43%	15.95%	19.19%	19.99%	15.48%	24.44%	26.88%
Net margin (%)	13.76%	16.86%	12.85%	51%	16.25%	11.79%	17.9%	19.25%
FCF margin (%)	15.03%	15.85%	13.01%	21.35%	17.98%	11.29%	17.11%	19.06%
FCF / Net Income (%)	109.21%	94.03%	101.19%	41.86%	110.67%	95.77%	95.62%	99.01%
Profitability
ROA	8.9%	7.18%	5.5%	8.08%	10.55%	8%	10.66%	11.28%
ROE	75.02%	44.39%	38.22%	43.85%	52.48%	45.36%	42.61%	41.23%
Financial Health
Leverage (Debt/EBITDA)	2.15x	2.18x	1.75x	1.65x	1.29x	1.35x	1.05x	0.69x
Debt / Free cash flow	5.07x	3.84x	4.47x	2.75x	2.76x	3.93x	2.11x	1.3x
Capital Intensity
CAPEX / Current Assets (%)	3.75%	3.6%	3.44%	3.9%	4.33%	4.42%	4.54%	4.51%
CAPEX / EBITDA (%)	10.57%	12.86%	10.34%	10.94%	11.29%	13.48%	13.22%	12.59%
CAPEX / FCF (%)	24.94%	22.68%	26.41%	18.26%	24.09%	39.17%	26.54%	23.69%
Items per share
Cash flow per share ¹	1.999	2.094	1.962	1.813	1.67	1.605	1.799	2.131
Change	-	4.79%	-6.3%	-7.63%	-7.86%	-3.91%	12.08%	18.45%
Dividend per Share ¹	1	1	1	0.6125	0.58	0.6031	0.6431	0.6908
Change	-	0%	0%	-38.75%	-5.31%	3.99%	6.63%	7.42%
Book Value Per Share ¹	3.024	3.661	3.758	2.627	3.294	3.611	4.115	4.923
Change	-	21.04%	2.65%	-30.09%	25.38%	9.64%	13.93%	19.64%
EPS ¹	1.158	1.426	1.082	3.662	1.216	0.899	1.409	1.602
Change	-	23.22%	-24.1%	238.29%	-66.79%	-26.07%	56.76%	13.65%
Nbr of stocks (in thousands)	3,959,572	3,982,185	4,006,383	4,060,999	4,076,145	4,080,500	4,080,500	4,080,500
Announcement Date	05/02/20	03/02/21	09/02/22	01/02/23	31/01/24	-	-	-